MiRNAs are short non-coding RNA molecules that have been shown to affect a vast number of genes at the post-transcriptional level, hence regulating several signaling pathways. Because the miRNA-34 family regulates a number of different signaling pathways, including those linked to cancer, the immune system, metabolism, cellular structure, and neurological disorders, it has garnered a great deal of attention from researchers. Members of the miRNA-34 family have been shown to inhibit tumors in a variety of cancer types. This family is also important for obesity, the cardiovascular system, and glycolysis. It's interesting to note that the miRNA-34 family is known to play a role in major depressive disorder, schizophrenia, Parkinson's disease (PD), adverse childhood experiences or trauma, regulation of stress responses, Alzheimer's disease (AD), and stress-related psychatric conditions. In this review, the expected targets of the miRNA-34 family are presented alongside the well-established targets identified by pathway analysis. Furthermore, the therapeutic potential of this miRNA family will be discussed.
Keyphrases
- major depressive disorder
- signaling pathway
- bipolar disorder
- gene expression
- metabolic syndrome
- type diabetes
- papillary thyroid
- emergency department
- epithelial mesenchymal transition
- transcription factor
- adipose tissue
- genome wide
- working memory
- cognitive decline
- dna methylation
- squamous cell
- cell proliferation
- young adults
- childhood cancer
- induced apoptosis
- electronic health record
- weight gain
- heat stress